Yoshifuji Ayumi, Wakino Shu, Irie Junichiro, Tajima Takaya, Hasegawa Kazuhiro, Kanda Takeshi, Tokuyama Hirobumi, Hayashi Koichi, Itoh Hiroshi
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Nephrol Dial Transplant. 2016 Mar;31(3):401-12. doi: 10.1093/ndt/gfv353. Epub 2015 Oct 20.
The role of gut microbiota in the progression of chronic kidney disease (CKD) has not been fully elucidated.
Renal failure was induced in 6-week-old spontaneously hypertensive rats by 5/6 nephrectomy (Nx). We analyzed the gut microbiota population to identify the relevant species potentially involved in inducing renal damage. Human colon Caco-2 cells were used to delineate the mechanism involved in the molecular changes in the gut of Nx rats.
Nx rats showed an increase in Bacteroides (Bact) and a decrease in Lactobacillus (Lact) species compared with sham-operated rats. Lact, but not Bact, populations were significantly associated with urinary protein excretion. Treatment of Nx rats with 1 × 10(10) CFU/kg/day Lact ameliorated increased urinary protein excretion and higher serum levels of the uremic toxins, indoxyl sulfate and p-cresyl sulfate, and serum urea nitrogen levels. Lact also attenuated systemic inflammation in Nx rats, as evaluated by serum lipopolysaccharide, interleukin-6 and C-reactive protein levels. Histologically, renal sclerosis in Nx rats was restored by Lact treatment. A reduction in the expression of tight junction proteins and the Toll-like receptor 2 (TLR2), a putative Lact receptor, in the colons of Nx rats were mitigated by Lact. Treatment of Caco-2 cells with indole downregulated tight junction protein expression, which was abolished by exposure to Lact. The effects of Lact were reversed by treatment with OxPAPC, a TLR inhibitor. Similarly, the increase in the permeability of the Caco-2 cell monolayer was reversed by the administration of Lact. Lact upregulated TLR2 expression in Caco-2 cells. Lact also attenuated the increase in serum indoxyl sulfate and urea levels and urinary protein excretion in Nx rats even in the pseudogerm-free environment.
Lact supplementation mitigated the systemic inflammation and proteinuria associated with renal failure, suggesting that in the gut microbiota, Lact plays a protective role against the progression of CKD.
肠道微生物群在慢性肾脏病(CKD)进展中的作用尚未完全阐明。
通过5/6肾切除术(Nx)诱导6周龄自发性高血压大鼠发生肾衰竭。我们分析了肠道微生物群组成,以确定可能参与诱导肾损伤的相关物种。使用人结肠Caco-2细胞来阐明Nx大鼠肠道分子变化所涉及的机制。
与假手术大鼠相比,Nx大鼠的拟杆菌属(Bact)增加,乳酸杆菌属(Lact)减少。Lact菌群数量,而非Bact菌群数量,与尿蛋白排泄显著相关。用1×10¹⁰CFU/kg/天的Lact治疗Nx大鼠,可改善尿蛋白排泄增加以及尿毒症毒素、硫酸吲哚酚和对甲酚硫酸盐血清水平升高和血清尿素氮水平升高的情况。Lact还减轻了Nx大鼠的全身炎症,这通过血清脂多糖、白细胞介素-6和C反应蛋白水平来评估。组织学上,Lact治疗可恢复Nx大鼠的肾硬化。Lact减轻了Nx大鼠结肠中紧密连接蛋白和Toll样受体2(TLR2,一种假定的Lact受体)表达的降低。用吲哚处理Caco-2细胞可下调紧密连接蛋白表达,而暴露于Lact可消除这种下调。用TLR抑制剂氧化型磷脂酰胆碱(OxPAPC)处理可逆转Lact的作用。同样,给予Lact可逆转Caco-2细胞单层通透性的增加。Lact上调了Caco-2细胞中TLR2的表达。即使在无特定病原体环境中,Lact也减轻了Nx大鼠血清硫酸吲哚酚和尿素水平的升高以及尿蛋白排泄。
补充Lact可减轻与肾衰竭相关的全身炎症和蛋白尿,表明在肠道微生物群中,Lact对CKD的进展起保护作用。